SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending after announcing record-high vehicle deliveries for December and the fourth quarter, significantly surpassing previous figures and nearing one million cumulative vehicles. This strong performance, further supported by extended EV subsidies in China, is driving considerable community discussion and optimism about the company's path to profitability and its competitive standing in the electric vehicle market.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions Inc. is trending following news of a strategic manufacturing partnership set to scale production of its drug screening reader for anticipated U.S. market entry. The community is actively discussing the stock's massive volume and micro-float, fueling excitement for potential short-squeeze-like parabolic gains. However, a recent private placement with lower-priced warrants has sparked debate among traders, creating a highly volatile environment with divided opinions on its immediate future.

Tidal Trust II - Defiance Daily Target 2x Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF

SMCX is currently trending amidst significant investor confusion and frustration surrounding a recent dividend event and persistent tracking discrepancies with its underlying asset, SMCI. The community is actively questioning the ETF's unusual behavior, with some alleging it's a "scam" or facing an imminent reverse split, while others view the current downturn as a potential buying opportunity despite concerns about leveraged product decay.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is currently a hot topic, with community discussion centering on the ongoing delay and mixed initial data for its inhaled cystic fibrosis therapy, ARCT-032, which showed some mucus plug reduction but not significant lung function improvements. Investors are closely monitoring an active trade secret lawsuit against AbbVie, generating widespread hope for a substantial settlement or potential acquisition. Many believe the company's advanced mRNA platform and solid cash runway make the stock deeply undervalued amidst significant short interest.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP Crypto is trending after a recent price surge ignited a polarized community discussion. Supporters emphasize its real-world utility through Flexa's merchant network and anticipate significant growth with pending regulatory clarity and strategic partnerships. However, many investors express deep frustration, warning of sustained manipulation and a history of pump-and-dump cycles despite its technological foundations.

SpaceX engineers reusable launch vehicles and the Starlink satellite constellation for global broadband. Their focus on rapid reusability and vertical integration drives down launch costs and accelerates space access.

SpaceX PreStocks

SpaceX is trending due to widespread anticipation of a potential IPO in 2026, which is igniting significant speculative interest across the broader aerospace sector. Community discussions are heavily focused on identifying "SpaceX IPO plays," with companies like Momentus ($MNTS) gaining traction for its partnership on Falcon 9 missions and a notably low share count, sparking comparisons to past explosive meme stock surges.

Grayscale Investments LLC - Grayscale Bitcoin Trust

Grayscale Bitcoin Trust

Grayscale Bitcoin Trust (GBTC) is trending amidst a fervent debate over Bitcoin's near-term price direction, with discussions highlighting recent ETF outflows and broader market dynamics. The community remains sharply divided, as many anticipate a "parabolic" rally for Bitcoin as a hedge against inflation, while others warn of an impending "crypto winter" and significant price corrections based on historical cycles and perceived lack of intrinsic value.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending amid intense community discussion following recent developments, including a partial summary judgment in its ongoing litigation and strategic changes to its executive team, which are fueling heightened speculation around a potential acquisition. Investors are closely monitoring progress for its rare disease therapy, MIPLYFFA, toward European market access and a patent term extension, while broadly criticizing management for perceived undervaluation and executive compensation. Despite these concerns, many maintain a bullish outlook, citing the company's significant cash reserves and pipeline assets as indicators of untapped value.

iShares Ethereum Trust (The) - Undivided Beneficial Interest

iShares Ethereum Trust ETF

iShares Ethereum Trust ETF ($ETHA) is a hot topic due to Ethereum's upcoming Fusaka upgrade and increasing institutional appetite for staked Ethereum ETFs. The community is actively discussing ETHA's role as a foundational asset for tokenization, with many seeing current price action as a prime opportunity to accumulate, anticipating significant long-term growth.

Viridian Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of proprietary RNA-targeted therapeutics. Its product candidates include Cobomarsen, which treats patients with certain cancers, including cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma, and Remlarsen and MRG-229, which are made for the treatment of patients with pathological fibrosis. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Viridian Therapeutics Inc

VRDN is trending as community members discuss recent analyst upgrades citing a differentiated profile relative to existing treatments for Thyroid Eye Disease (TED). The potential for M&A activity in 2026 is also fueling conversation, with some speculating on buyout prices. Community members are weighing the company's financial position, upcoming data readouts, and commercial launch plans in their analysis.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Volume Decline the Real Risk Behind Molson Coors' 2025 Outlook?

TAP's 2025 outlook hinges on falling beer volumes, as pricing and cost controls cannot offset a structurally soft U.S. industry.

VIRGINIA RETIREMENT SYSTEMS ET Al Has $27.27 Million Stock Holdings in Molson Coors Beverage Company $TAP

VIRGINIA RETIREMENT SYSTEMS ET Al cut its holdings in shares of Molson Coors Beverage Company (NYSE:TAP - Free Report) by 24.5% in the third quarter, according to its most recent filing with the...

34,100 Shares in Molson Coors Beverage Company $TAP Acquired by Polianta Ltd

Polianta Ltd bought a new stake in shares of Molson Coors Beverage Company (NYSE:TAP - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange...

Osaic Holdings Inc. Has $3.86 Million Position in Molson Coors Beverage Company $TAP

Osaic Holdings Inc. lifted its stake in shares of Molson Coors Beverage Company (NYSE:TAP - Free Report) by 220.0% in the second quarter, according to the company in its most recent filing with the...

Molson Coors Beverage Company (NYSE:TAP) Given Average Recommendation of "Hold" by Analysts

Molson Coors Beverage Company (NYSE:TAP - Get Free Report) has earned a consensus recommendation of "Hold" from the seventeen brokerages that are presently covering the firm, MarketBeat reports. Two...

Molson Coors Beverage Company (NYSE:TAP) Given Consensus Rating of "Hold" by Brokerages

Molson Coors Beverage Company (NYSE:TAP - Get Free Report) has received a consensus rating of "Hold" from the seventeen analysts that are presently covering the firm, MarketBeat Ratings reports. Two...

Beer's Big Comeback? 2 Stocks Poised to Benefit in 2026

Major global events could spark a beer demand rebound in 2026. See why Constellation Brands and Molson Coors may benefit from the shift...

Cramer's Stop Trading: Molson Coors

CNBC's Jim Cramer explains why he is keeping an eye on shares of Molson Coors...

Corient Private Wealth LLC Has $5.90 Million Stock Holdings in Molson Coors Beverage Company $TAP

Corient Private Wealth LLC lifted its holdings in shares of Molson Coors Beverage Company (NYSE:TAP - Free Report) by 76.0% during the 2nd quarter, according to the company in its most recent 13F...

Wilsey Asset Management Inc. Raises Position in Molson Coors Beverage Company $TAP

Wilsey Asset Management Inc. lifted its holdings in Molson Coors Beverage Company (NYSE:TAP - Free Report) by 4.9% in the third quarter, according to its most recent filing with the Securities and...

Molson Coors Beverage Co. is a holding company, which engages in the production and sale of beer. It operates through the Americas and EMEA and APAC geographical segments. The Americas segment imports, markets, distributes, and sells owned brands and partner brands and licensed brands in the U.S., Canada and various countries in Latin America. The EMEA and APAC segment consists of the production, marketing, and sales of primary brands as well as other owned and licensed brands in Bulgaria, Croatia, Czech Republic, Hungary, Montenegro, the Republic of Ireland, Romania, Serbia, the U.K., various other European countries and certain countries within the Middle East, Africa and Asia Pacific regions. The company was founded in 1786 and is headquartered in Golden, CO.

TAP
Molson Coors Beverage Company - Ordinary Shares - Class B

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TAP News

TAPMolson Coors Beverage Company - Ordinary Shares - Class B